Medically reviewed by Kathleen Daly, MD Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental ...
Rejection sensitive dysphoria is self-perceived shame and distress from rejections at work, school, online, or elsewhere.
People with ADHD are spending thousands of pounds on treatment and medication, with more than 400,000 private prescriptions ...
New research identifies differing trends in attention-deficit/hyperactivity disorder (ADHD) diagnoses among adolescents and adults, including an increase among adults from 2020 to 2023.
New research identifies differing trends in attention-deficit/hyperactivity disorder (ADHD) diagnoses among adolescents and adults, including an increase among adults from 2020 to 2023. The study ...
Did you know the attention, memory, and motivation challenges associated with ADHD are rooted in biology? Learn how the brain ...
Both children and adults with ADHD may show inattentiveness, excessive movement, impulsivity and challenges in executive ...
In a large network meta-analysis of pharmacological, psychological and neurostimulatory ADHD interventions, only stimulants ...
Cingulate Inc. (NASDAQ:CING) announced the successful completion of its final FDA-required study for CTx-1301 (dexmethylphenidate) aimed at treating Attention Deficit Hyperactivity Disorder (ADHD).